A-2021-000129

A-2021-000129 is the reference number for a completed FOI request from the Public Health Agency of Canada (PHAC). It focuses primarily on a series of e-mail communications between PHAC employees in regards to how to handle communications around ivermectin and public requests for its use to treat COVID-19.

Request details

Date	Records Requested	Request No.	Response Letter	Disclosure Package	Notes
April 2022	All communication regarding the use of Ivermectin in the treatment of Covid-19. Date range March 1, 2020 to June 7, 2021.	A-2021-000129	-	Disclosure	-

People

The following table outlines the individuals involved in the discussions/materials included in the document release.

Name	Affiliation	Position	Notes
Kristian Andersen	Scripps Research Institute	-	-
Jacqueline Arthur	Public Health Agency of Canada, Centre for Communicable Disease and Infection Control	Senior Manager, AMR Division	On page 17 of the disclosure, she comments on the membership of the Front Line COVID-19 Critical Care Alliance (FLCCC) saying, “Interesting membership, all white males…”
Mina Azad	Public Health Agency of Canada, Centre for Communicable Disease and Infection Control	Research Analyst, COVID-19 Therapeutics	PhD biochemist
Lizanne Beique	Public Health Agency of Canada	Senior Policy Analyst	-
Serena Cortés-Kaplan	Public Health Agency of Canada, COVID-19 Therapeutics, Centre for Communicable Disease and Infection Control	Student Analyst	-
Adéle Croteau	Public Health Agency of Canada	Issues Manager - COVID-19 Therapeutics¹⁾	-
Jaahnavi Dave	Public Health Agency of Canada	-	Researcher under BioCanRx, a Pfizer-funded network. Also published research on a COVID-19 vaccine candidate while working with PHAC and early treatment denial.
Joseph Djiometio	Public Health Agency of Canada, Centre for Communicable Disease and Infection Control	Technical Lead, COVID-19 Therapeutics	-
Laurent Duvernay-Tardif	-	-	-
Bersabel Ephrem	Public Health Agency of Canada, Centre for Communicable Disease and Infection Control	Director General	-
Nicole Forbes	Public Health Agency of Canada, National Advisory Committee on Immunization (NACI), Centre for Immunization Readiness²⁾	Scientific Project Coordinator	Alumni of BioCanRx
Stephan Gadient	Public Health Agency of Canada	-	-
Margaret Gale-Rowe	Public Health Agency of Canada	-	-
Shalane Ha	Public Health Agency of Canada	-	-
Emma Hodcroft	CoVariants, Institute of Social and Preventive Medicine, SIB Swiss Insitute of Bioinformatics	-	Signatory to the John Snow Memorandum
Linsey Hollett	Health Canada	-	-
Kelly Hunt	Public Health Agency of Canada	-	-
Marium Jamil	Public Health Agency of Canada, Office of the Chief Science Officer	Policy Analyst	-
Anna Jirovec	-	-	-
Marita Killen	Public Health Agency of Canada	-	-
Pierre Kory	Front Line COVID-19 Critical Care Alliance (FLCCC)	-	Contacted Andrew Morris to “spew anger” and advise Morris that he would be proven wrong about ivermectin.
Niyi Lawuyi	Public Health Agency of Canada	COVID-19 Therapeutics Team, Advisor to Director General³⁾	-
Kaili Levesque	Health Canada, Public Health Agency of Canada	Vice President, COVID-19 Vaccine Rollout	-
Erika Lingohr	Public Health Agency of Canada	Researcher	-
Syra Madad	-	-	Developed a “cheat sheet” that included staying home, wearing a mask, social distancing, avoiding crowds, close contact or confined spaces, opening windows, washing hands, cleaning high-touch surfaces, complying with contact tracing, listening to public health for updates, getting tested for SARS-CoV-2 periodically, getting transfected with a COVID-19 vaccine, monitoring for symptoms of COVID-19, and covering coughs/sneezes.
Jonathan Mahdi	Health Canada	-	-
Cheryl Marisnky	Public Health Agency of Canada	-	-
Hollie McLean	Health Canada	-	-
Andrew Morris	Ontario COVID-19 Science Advisory Table, University of Toronto, Sinai Health System, University Health Network	-	Writes “COVID Emails” newsletter. Chair of the Behavioural Science Working Group of the Ontario COVID-19 Science Advisory Table. Recommended his readers go outside and get sunlight.
Howard Njoo	Public Health Agency of Canada	Deputy Chief Public Health Officer	-
Pamela Ponic	Public Health Agency of Canada	-	-
Celisse Poon Young	Public Health Agency of Canada	Scheduling Assistant⁴⁾	-
Angela Rasmussen	-	-	Developed a “cheat sheet” that included staying home, wearing a mask, social distancing, avoiding crowds, close contact or confined spaces, opening windows, washing hands, cleaning high-touch surfaces, complying with contact tracing, listening to public health for updates, getting tested for SARS-CoV-2 periodically, getting transfected with a COVID-19 vaccine, monitoring for symptoms of COVID-19, and covering coughs/sneezes.
Marina Salvadori	Public Health Agency of Canada	-	Briefs Theresa Tam on “all things scientific”
Elaha Sarwar	Public Health Agency of Canada	-	-
Jennifer Siushansian	Public Health Agency of Canada	-	-
Theresa Tam	Public Health Agency of Canada	Chief Public Health Officer	-
Karen Timmerman	Public Health Agency of Canada	-	-
Lisa Waddell	Public Health Agency of Canada	-	-
Redacted	Alberta Health	-	-

Organizations

Therapeutics

Common name	Brand name	Other names	Company	Notes
Anakinra	Kineret	-	Swedish Orphan Biovitrum (Sobi)	-
Aspirin	-	-	-	-
Baricitinib	Olumiant	-	Incyte, Eli Lilly	-
Chloroquine	-	-	-	Not recommended in any context for COVID-19 by Health Canada
Colchicine	Colcrys, Mitigare, others	-	-	-
Convalescent plasma	-	-	-	-
Dexamethasone	-	-	-	-
Fluvoxamine	-	-	-	-
Hydroxychloroquine	-	-	-	Not recommended in any context for COVID-19 by Health Canada
Interferon	-	-	-	Not recommended in any context for COVID-19 by Health Canada
Ivermectin	Stromectol, Mectizan	-	Merck	Administered intravenously (IV) and orally in studies for the treatment of COVID-19. Authorized by Health Canada for the treatment of parasitic infections in humans and animals. Indicated in humans for the treatment of intestinal strongyloidiasis and onchoceriasis/rosacea. Not recommended for use outside of clinical trials.
Melatonin	-	-	-	-
Molnupiravir	-	MK-4482	Merck, Ridgeback Pharmaceuticals	-
Lopinavir/ritonavir	Kaletra	-	AbbVie	HIV/AIDS drug
Quercetin	-	-	-	-
Remdesivir	Veklury	GS-5734	Gilead Sciences	-
Vitamin C	-	Ascorbic acid, ascorbate	-	-
Vitamin D	-	-	-
Zinc	-	-	-	-
Monoclonal antibodies
Tixagevimab/cilgavimab	Evushield	AZD7442	AstraZeneca	-
Bamlanivimab	-	-	AbCellera, Eli Lilly	-
Casirivimab and/or imdevimab	-	-	Regeneron, Genentech	-
Otilimab	-	-	GlaxoSmithKline	-
Sarilumab	Kevzara	-	Sanofi, Regeneron	-
Tocilizumab	Actemra	-	Roche	-

Protocols

I-MASK+ Protocol

Clinical Trials

Trial Number	Name	Sponsor	Principal Investigator
NCT04527211	Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel (IveprofCovid19)	Javeriana University	Eduar Echeverri
NCT04405843	Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)	Centro de Estudios en Infectogía Pediatrica	Eduardo López-Medina
NCT04529525	Ivermectin to Prevent Hospitalizations in COVID-19 (IVERCORCOVID19)	Instituto de Cardiología de Corrientes	Rodrigo Zoni, Julio Vallejos

¹⁾

Shared Services Canada. (2020, October 10). Person Information - Adèle Crôteau - Issues Manager - COVID-19 Therapeutics. Government of Canada. https://web.archive.org/web/20221007045418/https://geds-sage.gc.ca/en/GEDS/?pgid=015&dn=Q049QURFTEUuQ1JPVEVBVUBQSEFDLUFTUEMuR0MuQ0EsT1U9REdPLUJERyxPVT1DQ0RJQy1DTENNVEksT1U9SURQQ0ItREdQQ01JLE9VPVBIQUMtQVNQQyxPPUdDLEM9Q0E=

²⁾

Where Are They Now: Nicole Forbes. (2020, November 20). BioCanRx. https://web.archive.org/web/20230316080334/https://biocanrx.com/now-nicole-forbes

³⁾

Shared Services Canada. (2020, October 10). Person Information - Niyi Lawuyi - Advisor to Director General. Government of Canada. https://web.archive.org/web/20221007045431/https://geds-sage.gc.ca/en/GEDS/?pgid=015&dn=Q049TklZSS5MQVdVWUlAUEhBQy1BU1BDLkdDLkNBLE9VPURHTy1CREcsT1U9Q0NESUMtQ0xDTVRJLE9VPUlEUENCLURHUENNSSxPVT1QSEFDLUFTUEMsTz1HQyxDPUNB

⁴⁾

Celisse Poon Young · Public Health Agency of Canada · Scheduling Assistant. OpenGovCA. Retrieved March 19, 2023, from https://web.archive.org/web/20230319202032/https://opengovca.com/employee/celisse-poon-young

Menu

Table of Contents